Latest Strategic Repositioning News

Hudson Investment Group signals potential corporate restructure as it explores sale and joint venture options for key Queensland and NSW properties.

Neurizon Therapeutics reports encouraging 8-month interim results for its ALS drug NUZ-001, secures Orphan Medicinal Product Designation in Europe, and raises $885,000 through a share placement, maintaining a robust $14 million cash position.

Peregrine Gold Limited has agreed to sell its Deadman Flat and Perry Creek Project to Capricorn Metals Ltd for A$1.5 million in shares, while maintaining upside through royalties and milestone payments. This deal strengthens Peregrine’s balance sheet and accelerates its focus on the Tin Can Trend exploration.

Insignia Financial reported a robust 2.2% increase in Funds Under Management and Administration to $326.8 billion in 2Q25, underpinned by strong net inflows and strategic milestones including the IT separation from NAB and the unveiling of its Vision2030 growth strategy.

Betashares Mrtn Currie Eqy Inc Fund (EINC) units have been suspended from trading on the ASX as of 22 January 2025, following a prior announcement in December 2024.